Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis: 3-year post-marketing surveillance study.
Sakae TanakaHideki MizutaniEri TsuruyaRyoko FukudaKiyoka KugeNaoki OkuboPublished in: Journal of bone and mineral metabolism (2021)
This study confirmed the long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis in daily clinical practice. No new safety signals were identified.